SPOTLIGHT -
EP. 1: Diagnosis and Prognosis of Follicular Lymphoma
EP. 2: Risk Assessment in Follicular Lymphoma
EP. 3: Up-Front Therapy in Follicular Lymphoma
EP. 4: Treatment Options for High-Risk Follicular Lymphoma Cases
EP. 5: Maintenance Therapy and MRD Testing in Follicular Lymphoma
EP. 6: Treating Relapsed or Refractory Follicular Lymphoma
EP. 7: Third-Line Treatments and Transplantation
EP. 8: Use of PI3K Inhibitors in Relapsed Follicular Lymphoma
EP. 9: Long-Term Efficacy and Safety of Copanlisib
EP. 10: Strategies for Therapeutic Sequencing Agents
EP. 11: Potential of R2 Regimen in Treating Follicular Lymphoma
EP. 12: Immunotherapeutic Agents Against Follicular Lymphoma
EP. 13: Emerging Therapies and Combinations
EP. 14: Cause for Optimism in Follicular Lymphoma Treatment
Up-Front Osimertinib Provides Comparable OS, Improved Brain PFS Vs Sequential Gefitinib/Osimertinib in EGFR+ NSCLC
Dr Nasioudis on the Use of NGS to Identify the Molecular Profile of Endometroid Ovarian Cancer
Dr Slomovitz on the Investigation of Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Carcinoma
Dr Westin on Outcomes of the SOLAR Trial in RAS-Mutant Gynecological Malignances
